In last trading session, Phreesia Inc (NYSE:PHR) saw 0.39 million shares changing hands with its beta currently measuring 0.85. Company’s recent per share price level of $15.71 trading at $0.09 or 0.58% at ring of the bell on the day assigns it a market valuation of $867.35M. That closing price of PHR’s stock is at a discount of -154.61% from its 52-week high price of $40.00 and is indicating a premium of 23.3% from its 52-week low price of $12.05. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.57 million shares which gives us an average trading volume of 573.78K if we extend that period to 3-months.

For Phreesia Inc (PHR), analysts’ consensus is at an average recommendation of a Buy while assigning it a mean rating of 1.43. Splitting up the data highlights that, out of 14 analysts covering the stock, 0 rated the stock as a Sell while 2 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 10 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.36 in the current quarter.

Phreesia Inc (NYSE:PHR) trade information

Upright in the green during last session for gaining 0.58%, in the last five days PHR remained trading in the green while hitting it’s week-highest on Wednesday, 11/15/23 when the stock touched $15.71 price level, adding 7.97% to its value on the day. Phreesia Inc’s shares saw a change of -51.45% in year-to-date performance and have moved 5.08% in past 5-day. Phreesia Inc (NYSE:PHR) showed a performance of -0.32% in past 30-days. Number of shares sold short was 2.36 million shares which calculate 3.93 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $35.92 to the stock, which implies a rise of 56.26% to its current value. Analysts have been projecting $29.00 as a low price target for the stock while placing it at a high target of $43.00. It follows that stock’s current price would drop -173.71% in reaching the projected high whereas dropping to the targeted low would mean a loss of -84.6% for stock’s current value.

Phreesia Inc (PHR) estimates and forecasts

Statistics highlight that Phreesia Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -48.46% of value to its shares in past 6 months, showing an annual growth rate of 22.02% while that of industry is 16.10. Apart from that, the company came raising its revenue forecast for fiscal year 2023. The company is estimating its revenue growth to increase by 25.00% in the current quarter and calculating 18.60% increase in the next quarter. This year revenue growth is estimated to rise 26.10% from the last financial year’s standing.

13 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $89.68 million for the same. And 13 analysts are in estimates of company making revenue of $94.92 million in the next quarter that will end on Jan 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -26.56% during past 5 years.

PHR Dividends

Phreesia Inc is more likely to be releasing its next quarterly report on December 05 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

Phreesia Inc (NYSE:PHR)’s Major holders

Insiders are in possession of 4.93% of company’s total shares while institution are holding 95.71 percent of that, with stock having share float percentage of 100.67%. Investors also watch the number of corporate investors in a company very closely, which is 95.71% institutions for Phreesia Inc that are currently holding shares of the company. FMR, LLC is the top institutional holder at PHR for having 7.23 million shares of worth $224.27 million. And as of Jun 29, 2023, it was holding 13.10% of the company’s outstanding shares.

The second largest institutional holder is Vanguard Group Inc, which was holding about 4.43 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 8.03% of outstanding shares, having a total worth of $137.44 million.

On the other hand, Fidelity Select Portfolios – Medical Technology & Devices Port and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of May 30, 2023, the former fund manager was holding 1.69 million shares of worth $50.73 million or 3.06% of the total outstanding shares. The later fund manager was in possession of 1.57 million shares on Jun 29, 2023, making its stake of worth around $48.78 million in the company or a holder of 2.85% of company’s stock.